GLP-1semaglutideoral semaglutideobesityjama network open

JAMA Network Open cohort tracks early oral semaglutide uptake in US obesity care

The study follows prescribing trends among adults eligible for obesity management medications after the oral formulation's approval for weight management.

By Maren Holt · Senior Reporter, GLP-1

Sep 30 20:00 ETSource: JAMA network open

The wire

01A cohort study published October 1 in JAMA Network Open evaluates early treatment trends for oral semaglutide among US adults with obesity who are eligible for obesity management medications.
02Prescribers and telehealth operators watching incretin uptake get an early read on how quickly an oral option diffuses relative to injectables after approval.
03Only the research-letter summary is available here; diffusion data so soon after approval reflects early adopters and may not predict steady-state prescribing or payer coverage.

From the source

Early Adoption and Diffusion of Oral Semaglutide in US Adults With Obesity
JAMA network open · 2026 Oct 1 · Lei Y, Tang H, Jian X et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42842253/